Funding
Furthr has facilitated over €200m of direct funding into Irish startups through its managed seed venture funds and angel networks. Furthr-supported companies have raised in excess of €500m of equity financing.
FurthrVC
Investing in the most ambitious founders who are building tomorrow.
We are a relationship-driven, early stage VC investor. We invest in and form close partnerships with the founders we back.
Our Investment Approach
We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.
In addition to providing institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds.
Our current fund has invested in some of Ireland’s most scalable and transformative tech start-ups at seed stage and beyond. The fund is backed by a number of leading tech entrepreneurs and business leaders as well as Enterprise Ireland. We have invested in 18 innovative software driven businesses and 6 medtech businesses. If you think your startup might be a fit for Furthr VC, get in touch below.
Our Key Impacts*
Since 1988 Furthr
has supported
start-ups.
6000
€200m
in direct funding support
through our Furthr
managed funding
channels since inception
The estimated total employment impact of Furthr supported companies in 2024 (direct, indirect and induced combined) was
969 jobs
In 2024 the total economic impact of Furthr supported clients (direct, indirect, and induced impact combined) was
€34.5m
€194m
The estimated aggregate
market value of Furthr
supported business based
on estimated post-money
valuation was
at year end 2024
In 2024, the direct
economic impact of
Furthr Clients was
at year end 2024
€17.7m
*Key Impact Stats are in relation to Furthr's Economic Impact Report 2022-2024 and not directly related to Furthr VC Impact.
Investment Criteria
Highly scalable, early-stage companies developing B2B software products and services, as well as Class I and II medical devices.
Product / Service:
-
B2B SaaS
-
Medtech
Location:
Republic of Ireland
Stage:
Seed to Series A Stage
Sector:
Sector agnostic
